Picture of Yungjin Pharm Co logo

003520 Yungjin Pharm Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapFalling Star

Annual cashflow statement for Yungjin Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-133-11,582-21,961-3,8761,233
Depreciation
Amortisation
Non-Cash Items8,81612,86724,10712,10214,481
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1,946-276-21,517-27,125-2,669
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities14,4988,368-11,610-10,22421,741
Capital Expenditures-6,305-11,320-13,200-10,238-21,607
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items652-318-152-2,7803,306
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-5,653-11,638-13,352-13,017-18,302
Financing Cash Flow Items-359-250-870-2,278-1,086
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-9,0663,30725,18029,766-7,212
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-22436.92186,525-3,772